CoChat

Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors

Open access
Federici, Cristina, Shahaj, Eriomina, Cecchetti, Serena, Camerini, Serena, Casella, Marialuisa, Iessi, Elisabetta, Camisaschi, Chiara, Paolino, Giovanni, Calvieri, Stefano, Ferro, Simona, Cova, Agata, Squarcina, Paola, Bertuccini, Lucia, Iosi, Francesca, Huber, Veronica, Lugini, Luana · 2020 · Frontiers in Immunology
Cited by 161

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Natural killer (NK) cells contribute to immunosurveillance and first-line defense in the control of tumor growth and metastasis diffusion. NK cell-derived extracellular vesicles (NKEVs) are constitutively secreted, are biologically active, reflect the protein and genetic repertoire of their originating cells and exert anti-tumor activity in vitro and in vivo. Cancer can compromise NK cell functions, a status potentially reflected by their EVs. Hence, NKEVs could on the one hand contribute to improve cancer therapy by interacting with tumor and/or immune cells and on the other hand sense the actual NK cell status in cancer patients. Here we investigated the composition of healthy donors’ NKEVs, including NK-microvesicles and exosomes, and their interaction with uncompromised cells of the immune system. To sense the systemic NK cell status in cancer patients we developed an immune enzymatic test (NKExoELISA) that measures plasma NK cell-derived exosomes, captured as tsg101+CD56+ nanovesicles. NKEV mass spectrometry and cytokine analysis showed the expression of NK cell markers i.e NKG2D and CD94, perforin, granzymes, CD40L and other molecules involved in cytotoxicity, homing, cell adhesion and immune activation, together with EV markers tsg101, CD81, CD63 and CD9 in both, NK-derived exosomes and microvesicles. Data are available via Proteome Xchange with identifier PXD014894. Immunomodulation studies revealed that NKEVs displayed main stimulatory functions in PBMCs, inducing the expression of HLA-DR and co-stimulatory molecules on monocytes and CD25 expression on T cells, which was maintained in the presence of LPS and IL-10/TGFβ, respectively. Furthermore, NKEVs increased the CD56+ NK cell fraction, suggesting that effects mediated by NKEVs might be potentially exploited in support of cancer therapy. The measurement of circulating NK exosomes in plasma of melanoma patients and healthy donors evidenced lower levels of tsg101+CD56+ exosomes in patients with respect to donors. Likewise, we detected lower frequencies of NK cells in PBMCs of these patients. This data highlights the potential of NKExoELISA to sense alterations of the NK cell immune status.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2020.00262

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 161

Metadata

Authors
Federici, C., Shahaj, E., Cecchetti, S., Camerini, S., Casella, M., Iessi, E., Camisaschi, C., Paolino, G., Calvieri, S., Ferro, S., Cova, A., Squarcina, P., Bertuccini, L., Iosi, F., Huber, V., & Lugini, L.
Venue
Frontiers in Immunology
Published
2020-03-13
Volume
11
Pages
262-262
ISSN
1664-3224 (ISSN-L)
OpenAlex
W3012416115
Cited by
161
References
12
FWCI
5.81
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors. https://app.cochat.ai/papers/10.3389/fimmu.2020.00262
The paper
Federici, C., Shahaj, E., Cecchetti, S., Camerini, S., Casella, M., Iessi, E., Camisaschi, C., Paolino, G., Calvieri, S., Ferro, S., Cova, A., Squarcina, P., Bertuccini, L., Iosi, F., Huber, V., & Lugini, L. (2020). Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.00262

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.